krm-ipo

KRM Ayurveda IPO

  • Status: Closed
  • RHP:
  • ₹ 256,000 / 2000 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    29 Jan 2026

  • Listing Price

    ₹ 172.10

  • Listing Change

    -

  • Last Traded Price

    ₹ 170.90

KRM Ayurveda IPO Details

  • Open Date

    21 Jan 2026

  • Close Date

    23 Jan 2026

  • Listing Date

    29 Jan 2026

  • IPO Price Range

    ₹ 128 to ₹135

  • IPO Size

    ₹ ₹ 77.49 Cr

  • Listing Exchange

    NSE SME

Open Free Demat Account

+91

By proceeding, you agree to all T&C*

hero_form

KRM Ayurveda IPO Subscription Status

Last Updated: 27 January 2026 11:53 AM by 5paisa

KRM Ayurveda, operates a network of 6 hospitals and 5 clinics across India and offers global telemedicine services. The company blends traditional Ayurvedic practices with modern medicine to provide personalized care for chronic, lifestyle, and preventive health needs. Services include in-patient and out-patient care, Panchakarma therapies, specialized clinics for various health concerns, wellness programs, in-house certified Ayurvedic medicines, and diet and lifestyle counseling. 

Established in: 2019 

Whole Time Director: Sanchit Hans 

Peers: 

Jeena Sikho Lifecare Ltd.  

Vaidya Sane Ayurved Laboratories Ltd

KRM Ayurveda Objectives

1. Fund construction and development of telemedicine facilities ₹13.67 Cr 

2. Acquire CRM software and supporting hardware ₹1.42 Cr 

3. Strengthen human resources and team capabilities ₹5.44 Cr 

4. Prepay or repay existing loans ₹12.50 Cr 

5. Support day-to-day working capital needs ₹18.00 Cr 

6. Meet general corporate purposes and operational expenses 

KRM Ayurveda IPO Size 

Types Size
Total IPO Size ₹77.49 Cr 
Offer For Sale -
Fresh Issue ₹77.49 Cr 

KRM Ayurveda IPO Lot Size 

Application Lots Shares Amount (₹)
Retail (Min) 2 2000  2,56,000 
Retail (Max) 2 2000  2,70,000 
S-HNI (Min) 3 3000  3,84,000 
S-HNI (MAX) 7 7000  9,45,000 
B-HNI (Min) 8 8000  10,24,000 

KRM Ayurveda IPO Reservation

Investors Category Subscription (times) Shares Offered* Shares bid for Total Amount (Cr.)*
QIB (Ex Anchor) 63.31 10,32,000 6,53,38,000 882.06
Non-Institutional Buyers 135.37 7,80,000 10,55,85,000 1,425.40
bNII (bids above ₹10L) 166.53 5,20,000 8,65,95,000 1,169.03
sNII (bids below ₹10L) 73.04 2,60,000 1,89,90,000 256.36
Individual Investors (IND category bidding for 2 Lots) 54.21 18,12,000 9,82,22,000 1,326.00
Total** 74.27 36,24,000 26,91,45,000 3,633.46

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (In ₹ Crores) FY23 FY24 FY25
Revenue 89.29  67.16  76.55 
EBITDA 11.03  7.34  19.11 
PAT 7.60  3.41  12.10 
Particulars (In ₹ Crores) FY23 FY24 FY25
Total Assets 39.48  43.91  66.79 
Share Capital 0.15  0.15  0.15 
Total Liabilities 39.47  43.91  66.78 
Cash Flows (₹ Crores) FY23 FY24 FY25
Net Cash Generated From / (used in) Operating Activities 3.50  - 0.89  0.03 
Net Cash Generated From / (used in) Investing Activities - 22.94  - 0.13  - 4.34 
Net Cash Generated From / (used in) Financing Activities 19.47  1.29  5.90 
Net Increase (Decrease) in Cash and Cash Equivalents 0.05  0. 27  1.54 


Strengths

1. Experienced Ayurvedic doctors and certified therapists ensure high-quality treatments 

2. Centralized GMP-certified production maintains medicine purity and effectiveness 

3. Trusted brand with strong customer loyalty and repeat clientele 

4. Established hospitals, clinics, and telemedicine with in-house product manufacturing. 

Weaknesses

1. Managing consistent quality across multiple locations is complex 

2. Reliance on availability of high-quality herbs and raw materials 

3. Limited brand recognition in newer markets 

4. Reliance on external logistics partners for raw material and product transport. 

Opportunities

1. Rising demand for natural and preventive healthcare solutions 

2. Growth in domestic and international Ayurvedic medical tourism 

3. Expansion through digital health and telemedicine services 

4. Launch of proprietary wellness products for retail and export markets 

Threats

1. Competition from modern healthcare and other Ayurveda chains 

2. Stringent regulatory and compliance requirements across states 

3. Economic downturns affecting patient spending capacity 

4. Misconceptions or misinformation potentially harming Ayurveda’s reputation 

1. Comprehensive wellness approach combining traditional Ayurvedic therapies with personalized yoga, diet, and meditation programs. 

2. Strategic expansion plans to strengthen North India presence and tap into new domestic and international markets. 

3. Robust training programs for therapists ensure high-quality care and operational efficiency across all locations. 

4. Strong regulatory compliance and quality accreditations enhance credibility, safety, and investor confidence.

1. Focus on holistic health by combining authentic Ayurvedic treatments with yoga, diet, and meditation. 

2. Expansion plans to deepen presence in North India and enter untapped domestic and international markets. 

3. Accredited training programs for therapists to strengthen service quality and operational expertise. 

4. Strict adherence to healthcare regulations and pursuit of quality accreditations to ensure credibility. 

5. Growing Ayurveda product distribution through hospitals, teleconsultation, and planned OTC channels to widen reach. 

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

FAQs

KRM Ayurveda IPO opens from January 21, 2026 to January 23, 2026. 

The size of KRM Ayurveda IPO is approximately ₹77.49 crore. 

The price band of KRM Ayurveda IPO is fixed at ₹128 to ₹135 per share. 

To apply for KRM Ayurveda IPO, follow the steps given below: 

●    Login to your 5paisa demat account and select the issue in the current IPO section     

●    Enter the number of lots and the price at which you wish to apply for the KRM Ayurveda. IPO.     

●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    

You will receive a mandate notification to block funds in your UPI app. 

The minimum lot size is 6000 shares, requiring an investment of approximately ₹2,82,000.  

The share allotment date of KRM Ayurveda IPO is January 27, 2026. 

The KRM Ayurveda IPO will likely be listed on January 29, 2026. 

NEXGEN Financial Solutions Pvt. Ltd. is the book-running lead manager. 

1. Develop and expand telemedicine operational facilities ₹13.67 Cr 

2. Procure CRM systems and IT infrastructure ₹1.42 Cr 

3. Invest in workforce enhancement and talent ₹5.44 Cr 

4. Repay or partially settle existing borrowings ₹12.50 Cr 

5. Fund routine working capital requirements ₹18.00 Cr 

6. Cover general corporate and business expenses